Orgenesis Balance Sheet Health
Financial Health criteria checks 2/6
Orgenesis has a total shareholder equity of $-21.0M and total debt of $22.3M, which brings its debt-to-equity ratio to -106.2%. Its total assets and total liabilities are $14.6M and $35.5M respectively.
Key information
-106.2%
Debt to equity ratio
US$22.29m
Debt
| Interest coverage ratio | n/a |
| Cash | US$837.00k |
| Equity | -US$20.98m |
| Total liabilities | US$35.54m |
| Total assets | US$14.55m |
Recent financial health updates
Recent updates
Orgenesis Inc.'s (NASDAQ:ORGS) Price Is Right But Growth Is Lacking After Shares Rocket 119%
Mar 04
Orgenesis GAAP EPS of $0.22 beats by $0.24, revenue of $7.2M beats by $0.2M
Aug 16Orgenesis gets FDA IDE approval for Tissue Genesis Icellator COVID-19 study
May 06Orgenesis shares rise after Bambino Gesù Children's Hospital collaboration
Apr 30Orgenesis (NASDAQ:ORGS) Has Debt But No Earnings; Should You Worry?
Feb 05
Orgenesis: A Cell And Gene Therapy Disruptor With A Nice Risk Reward Profile
Jan 28Did You Miss Orgenesis' (NASDAQ:ORGS) 71% Share Price Gain?
Dec 14Orgenesis reports Q3 results
Nov 06Financial Position Analysis
Short Term Liabilities: ORGS has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.
Long Term Liabilities: ORGS has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.
Debt to Equity History and Analysis
Debt Level: ORGS has negative shareholder equity, which is a more serious situation than a high debt level.
Reducing Debt: ORGS's has negative shareholder equity, so we do not need to check if its debt has reduced over time.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ORGS has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: ORGS is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.